ModelEdge
Processa Pharmaceuticals Inc.
PCSA
Filing type
8-K
Filing date
Jul 28, 2026
Updated
Jul 29, 2026 ยท 6:50 AM

Filing

8-KMaterial Contracts, End of Material Contract, Completing Asset Acquisition or Sale, Unregistered Sales of Equity Securities, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FD

Exhibits

EX-2.1EX-2.1EX-3.1EX-3.1EX-10.1EX-10.1EX-10.2EX-10.2EX-99.1Material Contracts, End of Material Contract, Completing Asset Acquisition or Sale, Unregistered Sales of Equity Securities, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FDEX-99.2Material Contracts, End of Material Contract, Completing Asset Acquisition or Sale, Unregistered Sales of Equity Securities, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FDGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphic